Evidence map›Paper›PMID 29783669›Full record

ArticleBiosensors2018

Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials.

Patrick Schrangl, Florian Reiterer, Lutz Heinemann, Guido Freckmann, Luigi Del Re

Abstract read
In one paragraph

Article in Biosensors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal HyperplasiaJournal of clinical research in pediatric endocrinology · 2023
    Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patrick SchranglInstitute for Design and Control of Mechatronical Systems, Johannes Kepler University Linz, 4040 Linz, Austria. patrick.schrangl@jku.at.
Florian ReitererInstitute for Design and Control of Mechatronical Systems, Johannes Kepler University Linz, 4040 Linz, Austria. florian.reiterer@jku.at.
Lutz HeinemannScience & Co, 41462 Neuss, Germany. lutz.heinemann@profil.com.
Guido FreckmannInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, 89081 Ulm, Germany. guido.freckmann@idt-ulm.de.ORCID 0000-0002-0406-9529
Luigi Del ReInstitute for Design and Control of Mechatronical Systems, Johannes Kepler University Linz, 4040 Linz, Austria. luigi.delre@jku.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systems for continuous glucose monitoring (CGM) are evolving quickly, and the data obtained are expected to become the basis for clinical decisions for many patients with diabetes in the near future. However, this requires that their analytical accuracy is sufficient. This accuracy is usually determined with clinical studies by comparing the data obtained by the given CGM system with blood glucose (BG) point measurements made with a so-called reference method. The latter is assumed to indicate the correct value of the target quantity. Unfortunately, due to the nature of the clinical trials and the approach used, such a comparison is subject to several effects which may lead to misleading results. While some reasons for the differences between the values obtained with CGM and BG point measurements are relatively well-known (e.g., measurement in different body compartments), others related to the clinical study protocols are less visible, but also quite important. In this review, we present a general picture of the topic as well as tools which allow to correct or at least to estimate the uncertainty of measures of CGM system performance.

Indexed as

Clinical Trials as TopicGlucoseMonitoring, AmbulatoryGlucoseblood glucosecontinuous glucose monitoringdiabetesquality of measurement

Identifiers

PMID29783669
PMCPMC6023102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.